DSE : ORIONINFU

Orion Infusion Limited — Key statistics

Biological Products, Except Diagnostic Substances · Bangladesh

Last price 228.7 BDT (At close: Oct 28, 2026) · Market cap 4.66B

Latest research: Orion Infusion financial analysis: ten flat years, 20% FY2025 sales fall and a 131x P/E (Oct 2026) · Orion Infusion: FY2025 sales fell 20% to BDT 665m and 9M FY2026 sales fell a further 3.5%, while the shares trade at 131x trailing earnings

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Key statistics

Valuation

MeasureValue
Market Cap4.63B
Enterprise Value4.90B

Dates

MeasureValue
Earnings DateNov 12, 2026
Ex-Dividend DateDec 2, 2025

Shares

MeasureValue
Current Share Class20.36M
Shares Outstanding20.36M
Shares Change (YoY)n/a
Shares Change (QoQ)+0.92%
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Ratios

MeasureValue
PE Ratio130.26
Forward PEn/a
PS Ratio7.14
PB Ratio14.01
P/TBV Ratio14.01
P/FCF Ratio70.11
P/OCF Ratio69.34
PEG Ration/a

Evratios

MeasureValue
EV / Earnings138.03
EV / Sales7.57
EV / EBITDA57.25
EV / EBIT66.44
EV / FCF74.29

Financialposition

MeasureValue
Current Ratio0.97
Quick Ratio0.35
Debt / Equity0.90
Debt / EBITDA3.45
Debt / FCF4.48
Interest Coverage2.15

Financialefficiency

MeasureValue
Return on Equity (ROE)10.93%
Return on Assets (ROA)5.47%
Return on Invested Capital (ROIC)9.73%
Return on Capital Employed (ROCE)20.41%
Weighted Average Cost of Capital (WACC)-4.75%
Revenue Per Employee1.15M
Profits Per Employee63,077
Employee Count563
Asset Turnover0.77
Inventory Turnover2.79

Taxes

MeasureValue
Income Tax9.02M
Effective Tax Rate20.26%

Stockprice

MeasureValue
Beta (5Y)-1.80
52-Week Price Change-55.13%
50-Day Moving Average232.93
200-Day Moving Average304.88
Relative Strength Index (RSI)43.41
Average Volume (20 Days)264,549

Shortselling

MeasureValue
Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Incomestatement

MeasureValue
Revenue647.55M
Gross Profit267.40M
Operating Income73.77M
Pretax Income44.53M
Net Income35.51M
EBITDA78.82M
EBIT73.77M
Earnings Per Share (EPS)1.74

Balancesheet

MeasureValue
Cash & Cash Equivalents13.52M
Total Debt295.63M
Net Cash-275.98M
Net Cash Per Share-13.56
Equity (Book Value)330.07M
Book Value Per Share16.21
Working Capital-14.00M

Cashflow

MeasureValue
Operating Cash Flow66.71M
Capital Expenditures-730,515
Depreciation & Amortization5.05M
Net Borrowing-29.81M
Free Cash Flow65.98M
FCF Per Share3.24

Margins

MeasureValue
Gross Margin41.29%
Operating Margin11.39%
Pretax Margin6.88%
Profit Margin5.48%
EBITDA Margin12.17%
EBIT Margin11.39%
FCF Margin10.19%

Dividends

MeasureValue
Dividend Per Share2.00
Dividend Yield0.88%
Dividend Growth (YoY)66.67%
Years of Dividend Growth2
Payout Ratio128.43%
FCF Payout Ratio61.72%
Buyback Yieldn/a
Shareholder Yield0.88%
Earnings Yield0.77%
FCF Yield1.43%

Analystforecasts

MeasureValue
Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Stocksplits

MeasureValue
Last Split DateDec 4, 2011
Split TypeForward
Split Ratio10

Scores

MeasureValue
Altman Z-Score10.8
Piotroski F-Score5

Fairvalue

MeasureValue
Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside